SyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3D
SyntheticMR announced today that their next-generation imaging solution with isotropic resolution, SyMRI 3D, has received FDA 510(k) clearance for clinical use in the United States.
Dela artikeln
Taggar: syntheticmr, receives, 510(k)
Läs vidare på Dagens IndustriRelaterade nyheter
- Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients
- SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-Marking
- SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D